Alpha 2.0
Login Register
» Articles » PMID: 2562938

Therapeutic Options in the Management of Chronic Heart Failure. Is There a Drug of First Choice?

Overview
Journal Circulation
Specialty Cardiology & Vascular Diseases
Date 1989 Jan 1
PMID 2562938
Citations 7
Authors
M Packer
Affiliations
Soon will be listed here.
Citing Articles

CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.

Li Y, Hu H, Wang Y, Fan Y, Yang Y, Guo B Oncogenesis. 2020; 9(2):20.

PMID: 32054830 PMC: 7018700. DOI: 10.1038/s41389-020-0206-3.

Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.

Widimsky J, Kremer H, Jerie P, UHLIR O Eur J Clin Pharmacol. 1995; 49(1-2):95-102.

PMID: 8751029 DOI: 10.1007/BF00192366.

The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy.

Lewis A, Chabot M Pediatr Cardiol. 1993; 14(1):9-12.

PMID: 8456034 DOI: 10.1007/BF00794837.

Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.

MacFadyen R, Lees K, Reid J Br Heart J. 1993; 69(4):293-7.

PMID: 8387806 PMC: 1025039. DOI: 10.1136/hrt.69.4.293.

Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.

McDonald K, OSullivan J, McWilliams E, Conroy R, Maurer B Cardiovasc Drugs Ther. 1989; 3(6):913-8.

PMID: 2535057 DOI: 10.1007/BF01869581.